PTK2 and cancer: FAK is a multifunctional non-receptor tyrosine kinase whose overexpression and activation has been linked to tumour progression, survival, migration, invasion, epithelial-to-mesenchymal transition (EMT), and drug resistance through effects on the cancer cells as well as stromal cells of the tumour microenvironment [1,2].